Rare Disease Gene Therapy Guidance Gives More Flexibility On Placebo-Controlled Trials

PS2002_Plastic Men_1074052661_1200.jpg
Rare diseases are the focus of one of six gene therapy final guidances from the US FDA. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Cell & Gene Therapies

More from Advanced Technologies